FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110169072> ?p ?o ?g. }

• W2110169072 endingPage "2540" @default.
• W2110169072 startingPage "2536" @default.
• W2110169072 abstract "To present clinical experience with a regimen including abacavir/lamivudine + darunavir/ritonavir in a cohort of HIV-1-infected patients. A retrospective, multicentre cohort study, including all consecutive adult HIV-1-infected patients who started abacavir/lamivudine + darunavir/ritonavir from April 2008 to December 2010 and had at least one follow-up visit. The primary endpoint was HIV-1 viral load (VL) <40 copies/mL at week 48. One hundred and eighty-three patients (42 naive and 141 experienced) from 19 hospitals in Spain were studied. The median follow-up was 26.7 (0.5–58.6) months, 79.8% were men, the median age was 47.1 (21.4–80.5) years, 26.2% had AIDS and 38.8% were positive for hepatitis C virus. At baseline, the median CD4 count was 246 cells/mm3 in naive patients and 393 cells/mm3 in experienced patients and the median VL was 4.80 and <1.59 log copies/mL, respectively. At week 48, 81.8% of naive patients and 84.2% of experienced patients receiving the regimen reached a VL <40 copies/mL, whereas at 96 weeks this occurred in 90.5% and 92.8%, respectively. CD4 cell count increases at 48 and 96 weeks were +176.5 and +283.5 cells/mm3 in naive patients and +74.9 and +93 cells/mm3 in experienced patients, respectively. Overall, 86 (47%) patients discontinued the study regimen, in many cases possibly related to non-medical reasons, such as drug switches to reduce cost or changes in address due to economic constraints. Three patients died of causes unrelated to therapy and 19 (10.4%) discontinued the regimen due to adverse events. In our cohort, abacavir/lamivudine + darunavir/ritonavir was safe, well tolerated and achieved high rates of virological suppression. In a proportion of patients, discontinuation of this effective regimen was possibly due to non-medical reasons." @default.
• W2110169072 created "2016-06-24" @default.
• W2110169072 creator A5000679352 @default.
• W2110169072 creator A5003776429 @default.
• W2110169072 creator A5012384912 @default.
• W2110169072 creator A5019841865 @default.
• W2110169072 creator A5028130303 @default.
• W2110169072 creator A5030091244 @default.
• W2110169072 creator A5032925281 @default.
• W2110169072 creator A5037760433 @default.
• W2110169072 creator A5042618056 @default.
• W2110169072 creator A5042665217 @default.
• W2110169072 creator A5043509211 @default.
• W2110169072 creator A5045428298 @default.
• W2110169072 creator A5048617361 @default.
• W2110169072 creator A5049645483 @default.
• W2110169072 creator A5049809112 @default.
• W2110169072 creator A5053140952 @default.
• W2110169072 creator A5053844368 @default.
• W2110169072 creator A5055739748 @default.
• W2110169072 creator A5065839556 @default.
• W2110169072 creator A5068859463 @default.
• W2110169072 creator A5074746574 @default.
• W2110169072 creator A5076780201 @default.
• W2110169072 creator A5080754332 @default.
• W2110169072 creator A5086210878 @default.
• W2110169072 creator A5087791132 @default.
• W2110169072 date "2014-05-15" @default.
• W2110169072 modified "2023-10-16" @default.
• W2110169072 title "Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients" @default.
• W2110169072 cites W1767400858 @default.
• W2110169072 cites W2012794817 @default.
• W2110169072 cites W2111884657 @default.
• W2110169072 cites W2167865974 @default.
• W2110169072 cites W2332910040 @default.
• W2110169072 doi "https://doi.org/10.1093/jac/dku157" @default.
• W2110169072 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24833755" @default.
• W2110169072 hasPublicationYear "2014" @default.
• W2110169072 type Work @default.
• W2110169072 sameAs 2110169072 @default.
• W2110169072 citedByCount "7" @default.
• W2110169072 countsByYear W21101690722015 @default.
• W2110169072 countsByYear W21101690722016 @default.
• W2110169072 countsByYear W21101690722018 @default.
• W2110169072 countsByYear W21101690722019 @default.
• W2110169072 countsByYear W21101690722021 @default.
• W2110169072 crossrefType "journal-article" @default.
• W2110169072 hasAuthorship W2110169072A5000679352 @default.
• W2110169072 hasAuthorship W2110169072A5003776429 @default.
• W2110169072 hasAuthorship W2110169072A5012384912 @default.
• W2110169072 hasAuthorship W2110169072A5019841865 @default.
• W2110169072 hasAuthorship W2110169072A5028130303 @default.
• W2110169072 hasAuthorship W2110169072A5030091244 @default.
• W2110169072 hasAuthorship W2110169072A5032925281 @default.
• W2110169072 hasAuthorship W2110169072A5037760433 @default.
• W2110169072 hasAuthorship W2110169072A5042618056 @default.
• W2110169072 hasAuthorship W2110169072A5042665217 @default.
• W2110169072 hasAuthorship W2110169072A5043509211 @default.
• W2110169072 hasAuthorship W2110169072A5045428298 @default.
• W2110169072 hasAuthorship W2110169072A5048617361 @default.
• W2110169072 hasAuthorship W2110169072A5049645483 @default.
• W2110169072 hasAuthorship W2110169072A5049809112 @default.
• W2110169072 hasAuthorship W2110169072A5053140952 @default.
• W2110169072 hasAuthorship W2110169072A5053844368 @default.
• W2110169072 hasAuthorship W2110169072A5055739748 @default.
• W2110169072 hasAuthorship W2110169072A5065839556 @default.
• W2110169072 hasAuthorship W2110169072A5068859463 @default.
• W2110169072 hasAuthorship W2110169072A5074746574 @default.
• W2110169072 hasAuthorship W2110169072A5076780201 @default.
• W2110169072 hasAuthorship W2110169072A5080754332 @default.
• W2110169072 hasAuthorship W2110169072A5086210878 @default.
• W2110169072 hasAuthorship W2110169072A5087791132 @default.
• W2110169072 hasBestOaLocation W21101690721 @default.
• W2110169072 hasConcept C126322002 @default.
• W2110169072 hasConcept C141071460 @default.
• W2110169072 hasConcept C142462285 @default.
• W2110169072 hasConcept C159047783 @default.
• W2110169072 hasConcept C2522874641 @default.
• W2110169072 hasConcept C2777869810 @default.
• W2110169072 hasConcept C2779182219 @default.
• W2110169072 hasConcept C2779298103 @default.
• W2110169072 hasConcept C2779465607 @default.
• W2110169072 hasConcept C2780593183 @default.
• W2110169072 hasConcept C2781413609 @default.
• W2110169072 hasConcept C2993143319 @default.
• W2110169072 hasConcept C3013748606 @default.
• W2110169072 hasConcept C71924100 @default.
• W2110169072 hasConcept C90924648 @default.
• W2110169072 hasConceptScore W2110169072C126322002 @default.
• W2110169072 hasConceptScore W2110169072C141071460 @default.
• W2110169072 hasConceptScore W2110169072C142462285 @default.
• W2110169072 hasConceptScore W2110169072C159047783 @default.
• W2110169072 hasConceptScore W2110169072C2522874641 @default.
• W2110169072 hasConceptScore W2110169072C2777869810 @default.
• W2110169072 hasConceptScore W2110169072C2779182219 @default.
• W2110169072 hasConceptScore W2110169072C2779298103 @default.
• W2110169072 hasConceptScore W2110169072C2779465607 @default.
• W2110169072 hasConceptScore W2110169072C2780593183 @default.

• next